| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 14.514 | 28.337 | 47.913 | 99.626 | 41.501 | 53.918 | 40.930 | 57.508 | 50.419 | 62.782 |
| Total Income - EUR | 14.514 | 28.337 | 47.938 | 99.695 | 42.089 | 53.944 | 44.575 | 59.355 | 52.243 | 64.595 |
| Total Expenses - EUR | 13.892 | 18.561 | 38.679 | 87.991 | 39.718 | 29.311 | 31.754 | 29.740 | 32.802 | 33.359 |
| Gross Profit/Loss - EUR | 622 | 9.776 | 9.259 | 11.704 | 2.371 | 24.633 | 12.821 | 29.615 | 19.441 | 31.235 |
| Net Profit/Loss - EUR | 187 | 8.926 | 7.821 | 10.708 | 1.779 | 23.113 | 12.264 | 29.104 | 18.962 | 30.292 |
| Employees | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Genetix Plus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 853 | 655 | 43.060 | 29.984 | 17.414 | 5.411 | 35.198 | 28.020 | 22.683 | 14.947 |
| Current Assets | 32.407 | 41.924 | 49.121 | 63.923 | 65.425 | 92.732 | 99.463 | 122.154 | 111.244 | 116.368 |
| Inventories | 1.481 | 2.614 | 2.795 | 2.760 | 3.017 | 3.283 | 3.210 | 3.220 | 3.211 | 3.193 |
| Receivables | 866 | 4.252 | 12.426 | 16.840 | 27.958 | 59.791 | 78.425 | 92.473 | 100.293 | 103.924 |
| Cash | 30.059 | 35.058 | 33.900 | 44.323 | 34.450 | 29.658 | 17.827 | 26.460 | 7.741 | 9.252 |
| Shareholders Funds | 30.670 | 39.283 | 46.439 | 56.295 | 56.983 | 79.016 | 89.528 | 112.506 | 98.604 | 104.855 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.589 | 3.296 | 45.741 | 37.612 | 25.856 | 19.128 | 36.340 | 30.672 | 30.168 | 23.144 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 8.794 | 6.996 | 5.155 | 3.317 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6202 - 6202" | |||||||||
| CAEN Financial Year |
6202
|
|||||||||
Comments - Genetix Plus Srl